Morphotek
As of the edition of 20 October 2026, Morphotek runs 6 drugs; it is on route A at 4 targets and on route B at 0 targets.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
Morphotek was acquired.
- Morphotek: acquired
Drugs by status
| Status | Count |
|---|---|
| Went quiet | 3 |
| Stopped | 3 |
| Total | 6 |
Where it needs a new molecule
Route A at 4 targets, route B at 0 targets.
All 4 rows on route A or B
In the product4 company-target rows on route A or B; 1 is not shown here, and no score is.
See all 4 targets where Morphotek needs a new molecule, with the facts behind eachRequest access. Nothing is shown until you do.
Where its trials are
- Cancer: 14 trials led
- Hormones: 8 trials led
- Digestive system: 5 trials led